# Kisspeptin FAQ: Common Questions, Answered from the Research

> Kisspeptin FAQ: the KISS1 gene, metastin, the GPR54/KISS1R receptor, isoforms, fertility and testosterone effects, half-life, and tachyphylaxis — direct answers, cited to the literature.

The questions readers actually ask about kisspeptin — the gene, the receptor, the isoforms, and the human findings — answered plainly and cited.

## What is the KISS1 gene?

KISS1 is the gene on chromosome 1q32 that encodes the kisspeptin peptides. It was first identified in 1996 as a metastasis-suppressor gene in melanoma, and its protein product later proved to be the master upstream activator of the reproductive axis [8]. Loss-of-function KISS1 mutations cause failure of puberty in humans [11].

## What is metastin and how does it relate to kisspeptin?

Metastin is the original name given to kisspeptin-54 when KISS1 was identified as a metastasis-suppressor gene in 1996 [8]. The two names refer to the same 54-residue peptide; "metastin" reflects its cancer-suppressing role, while "kisspeptin-54" reflects its later-discovered reproductive role. Older papers tend to use metastin.

## How was kisspeptin discovered?

Kisspeptin was discovered backwards. In 1996 the KISS1 gene was found as a metastasis suppressor in melanoma, named for Hershey, Pennsylvania [8]. Its orphan receptor GPR54 was deorphanized around 2001, and in 2003 loss-of-function GPR54 mutations were shown to cause failure of puberty, recasting kisspeptin as the reproductive master switch [1].

## What happens when GPR54 mutations are present in patients with delayed puberty?

Loss-of-function mutations in GPR54 (KISS1R) cause autosomal-recessive idiopathic hypogonadotropic hypogonadism with failure of puberty: affected people have low LH and FSH and do not progress through puberty normally, and Gpr54-knockout mice reproduce the phenotype [1]. The finding established GPR54 as a gatekeeper of reproductive maturation.

## Can kisspeptin help distinguish congenital hypogonadotropic hypogonadism from constitutional delayed puberty?

A kisspeptin challenge produces divergent LH responses in children with delayed puberty, with a subset showing robust, adult-like responses [12]. That heterogeneity suggests kisspeptin responsiveness may help characterize how far the pubertal axis has matured — an investigational research use, not an approved diagnostic test.

## Does kisspeptin signaling have a role in the testes directly?

Kisspeptin's established role is central — it acts upstream on hypothalamic GnRH neurons to drive LH and FSH, which then drive testicular testosterone [3]. KISS1 and KISS1R are also expressed in the gonads, but the dominant, well-characterized mechanism behind its effects on male hormones is the central HPG cascade, not a direct testicular action.

## What is kisspeptin?

Kisspeptin is a family of neuropeptides encoded by the KISS1 gene and the principal upstream activator of GnRH neurons — the master switch of the reproductive (HPG) axis [1]. It binds the KISS1R (GPR54) receptor and triggers pulsatile GnRH release. It is investigational, with no regulatory approval for any indication, and is not a dietary supplement.

## What does kisspeptin do?

Kisspeptin switches on the reproductive axis. It binds KISS1R on GnRH neurons, makes them fire in pulses, and that GnRH drives the pituitary to release LH and FSH, which drive the sex steroids [1]. In trials it raises LH and, in men, testosterone [3], and it can restore lost LH pulses or trigger egg maturation for IVF [5].

## Does kisspeptin increase testosterone?

Yes, indirectly, in studied settings. In healthy men, a kisspeptin-10 infusion at 4 ug/kg/h raised serum testosterone from 16.6 to 24.0 nmol/L, and lower doses raised LH and LH pulse frequency [3]. Kisspeptin does this by driving the body's own GnRH-LH cascade, not by supplying testosterone directly.

## How much does kisspeptin increase testosterone?

In one healthy-men study, continuous IV kisspeptin-10 at 4 ug/kg/h raised serum testosterone from 16.6 to 24.0 nmol/L, an increase of about 45% over baseline within the study window [3]. This is a study-attributed result at a specific dose and route in healthy men; it is not a dose recommendation and individual responses are not characterized.

## What is kisspeptin used for in research?

Kisspeptin is studied for IVF oocyte-maturation triggering (with lower OHSS risk) [5], restoring LH pulses in hypothalamic amenorrhea [4], probing puberty disorders [12], and the brain circuitry of sexual desire. A 2025 systematic review catalogued 29 interventional trials across these and related areas; none has led to an approved product [7].

## Can kisspeptin help with fertility?

In fertility research it shows real promise. A Phase 2 trial used subcutaneous kisspeptin-54 to trigger oocyte maturation in 95% of women at high OHSS risk with no moderate-or-worse OHSS, and a 62% live-birth rate at the best dose [5]. It also restored LH pulsatility in women with hypothalamic amenorrhea [4]. It remains investigational, not an approved fertility treatment.

## Can kisspeptin restore ovulation in women with hypothalamic amenorrhea?

Continuous IV kisspeptin-54 (0.01-1.00 nmol/kg/h) restored pulsatile LH secretion in women with hypothalamic amenorrhea — LH pulses rose from 1.6 to 5.0 per 8 hours (about three-fold) versus vehicle [4]. Restoring LH pulsatility is the upstream requirement for ovulation, though the highest infusion dose produced tachyphylaxis.

## What is the difference between kisspeptin-10 and kisspeptin-54?

Both are active kisspeptin isoforms sharing the same C-terminal RF-amide motif and the same receptor. Kisspeptin-10 is a 10-residue fragment (about 1302.5 Da) cleared in roughly 4 minutes; kisspeptin-54 (about 5857 Da, originally named metastin) is more cleavage-resistant and lasts about 27-28 minutes [3]. KP-10 suits pulse studies; KP-54 suits triggers and infusions.

## What receptor does kisspeptin bind?

Kisspeptin binds KISS1R, a Gq/11-coupled G-protein-coupled receptor formerly called GPR54 (and historically hOT7T175 or AXOR12), expressed on hypothalamic GnRH neurons [1]. Loss-of-function mutations in this receptor cause failure of puberty; gain-of-function mutations cause precocious puberty [10], which is how its role was established.

## How does kisspeptin work in the body?

Kisspeptin binds KISS1R on GnRH neurons and, through a PLC/IP3/calcium cascade, depolarizes them so they fire in pulses [2]. That pulsatile GnRH drives the pituitary to release LH and FSH, which drive the gonadal sex steroids [1]. Kisspeptin sits at the top of this HPG cascade as the upstream master switch.

## How long does kisspeptin take to work?

Fast. In healthy men, an IV kisspeptin-10 bolus produced maximal LH stimulation by about 30 minutes (LH 4.1 to 12.4 IU/L) [3], and intranasal kisspeptin-54 raised LH rapidly after dosing [6]. The hormonal response is acute — within minutes to tens of minutes — though it fades with continuous dosing due to receptor desensitization.

## What is the half-life of kisspeptin?

It depends on the isoform. Kisspeptin-10 has a functional half-life of roughly 4 minutes in humans, cleared quickly by plasma peptidases; kisspeptin-54 lasts longer, about 27-28 minutes, because of its larger size and greater resistance to cleavage [3]. That difference shapes which isoform is used for which study design.

## What is the mechanism by which kisspeptin-10 exerts its effects?

Kisspeptin-10 binds KISS1R on GnRH neurons and triggers a phospholipase C / IP3 / intracellular-calcium cascade that closes potassium channels and opens cation channels, depolarizing the neuron and increasing firing — measured as a 6 ± 1 mV depolarization and an 87 ± 4% firing increase in mouse GnRH neurons [2]. The resulting pulsatile GnRH drives LH and FSH.

## How does stress suppress kisspeptin and disrupt the reproductive axis?

Functional suppression of GnRH pulsatility — often from low body weight, heavy exercise, or stress — underlies hypothalamic amenorrhea and is associated with reduced kisspeptin-neuron activity. The evidence that kisspeptin is the missing upstream signal is that giving kisspeptin-54 restores LH pulsatility in these women, raising LH pulses roughly three-fold versus vehicle [4].

## How does kisspeptin reduce OHSS risk compared to hCG as an IVF trigger?

Kisspeptin triggers the body's own short, self-limiting LH surge rather than a sustained external stimulus, so the ovaries are not over-driven. In a Phase 2 trial, subcutaneous kisspeptin-54 matured eggs in 95% of high-risk women with no case of moderate, severe, or critical OHSS [5] — the mechanistic basis for it being a safer trigger in OHSS-prone patients.

## Can kisspeptin-54 trigger ovulation more safely than GnRH agonists in IVF?

The kisspeptin-54 evidence shows effective oocyte-maturation triggering with no moderate-or-worse OHSS across all studied doses, and a 62% live-birth rate at the best dose [5]. Because kisspeptin acts upstream to elicit the body's own LH surge, it offers a mechanistically gentle trigger; head-to-head superiority over every alternative trigger remains under investigation, and no product is approved.

---

A discovery-first reading of the Kisspeptin record — the KISS1 gene traced from metastasis suppressor to the master switch above GnRH, every human finding logged to its source and the not-approved, not-a-supplement status held in plain sight; no clinic behind the cascade, and nothing here dosed, dispensed, or sold.